[New model]Rat CCl4-induced Acute Liver Injury Model
New In Vivo Model
Rat CCl4-induced
Acute Liver Injury Model
Accelerate the efficacy evaluation of your hepatoprotective and anti-inflammatory drugs with our reliable and precise new model.
Facing Challenges in Liver Disease Drug Development?
Need to evaluate hepatoprotective effects with a reliable in vivo model?
Looking to quickly narrow down candidate compounds and shorten your development timeline?
Want to consult on a flexible study design that aligns with your specific research plan?
If any of these sound familiar, we can help.
Three Key Advantages of Our Model
1
Highly Reliable Data
Our model shows a confirmed, obvious increase of ALT/AST at 24 and 48 hours post-administration, ensuring a robust and reproducible window for evaluation.
2
Precise MoA Analysis
Enable multi-faceted evaluation of your compounds. Evaluation of regeneration factors is available 48 hours after administration to analyze mechanisms of action.
3
Flexible Customization
We work with you to design the optimal study plan, tailored to the specific needs and goals of your project for maximum relevance and impact.
Model Characterization Data
Ready to Advance Your Research?
• Want to see other data or detailed protocols?
• Like to discuss testing feasibility for your compound?
Please feel free to reach out with any questions. We are ready to strongly support your drug development program.